Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain

Emerg Infect Dis. 2008 Nov;14(11):1807-9. doi: 10.3201/eid1411.080517.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Capsid Proteins / genetics
  • Child
  • Disease Outbreaks*
  • Fatal Outcome
  • Humans
  • Immunocompromised Host
  • Infant
  • Male
  • Paralysis / virology*
  • Poliomyelitis / epidemiology*
  • Poliomyelitis / etiology
  • Poliomyelitis / prevention & control
  • Poliomyelitis / transmission*
  • Poliovirus Vaccine, Oral / administration & dosage
  • Poliovirus Vaccine, Oral / adverse effects*
  • Poliovirus Vaccine, Oral / genetics
  • Sequence Homology, Amino Acid
  • Spain / epidemiology
  • Vaccination / adverse effects*
  • Vaccination / standards
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / adverse effects
  • Vaccines, Synthetic / genetics

Substances

  • Capsid Proteins
  • Poliovirus Vaccine, Oral
  • VP1 protein, Poliovirus
  • Vaccines, Synthetic